CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-23 | KREHER NERISSA Director | Grant or award · Director Stock Options (Right to Buy) | +30,000 | 30,000 | ||
| 2023-07-03 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +5,000 | $1.90 | $9K | 27,552 |
| 2022-07-22 | HANDOK, INC. Director | Purchase | +3,157,895 | $3.80 | $12.0M | 5,942,617 |
| 2022-07-22 | Kim Young-Jin Director | Purchase | +78,947 | $3.80 | $300K | 78,947 |
| 2022-06-23 | Kim Young-Jin Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-23 | FAUCHET PHILIPPE Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-06-23 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Grant or award · Stock Option (right to buy) | +700,000 | 700,000 | ||
| 2022-06-23 | Hogenhuis Wladimir Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-06-23 | Elam Nevan C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +2,600,000 | 2,600,000 | ||
| 2022-06-23 | Labrucherie Gil M Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-06-23 | KREHER NERISSA Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-05-19 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Purchase | +300 | $2.95 | $884 | 22,552 |
| 2022-05-18 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Purchase | +200 | $2.86 | $572 | 22,252 |
| 2022-05-17 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Purchase | +1,000 | $3.41 | $3K | 22,052 |
| 2022-05-04 | Labrucherie Gil M Director | Purchase | +52,631 | $3.80 | $200K | 53,572 |
| 2022-05-04 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Purchase | +21,052 | $3.80 | $80K | 21,052 |
| 2022-05-04 | Labrucherie Gil M Director | Purchase | +52,631 | $3.80 | $200K | 52,631 |
| 2022-05-04 | Hogenhuis Wladimir Director | Purchase | +25,000 | $3.80 | $95K | 32,693 |
| 2021-10-15 | HANDOK, INC. Director | Purchase | +769,231 | $6.50 | $5.0M | 2,784,722 |
| 2021-10-15 | Hogenhuis Wladimir Director | Purchase | +7,693 | $6.50 | $50K | 7,693 |
Page 7 of 14 · 279 trades